Comments
Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration to manufacture and market Levofloxacin Injection.
Levofloxacin injection is the generic equivalent of Janssen Pharmaceuticals Inc’s Levaquin injection. It is indicated for the treatment of adults with mild, moderate, and severe infections caused by susceptible isolates of the designated micro-organisms such as pneumonia.
The product would be marketed and sold by the Hyderabad-based company’s US subsidiary AuroMedics Pharma LLC, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.